Gamma Knife Market To Witness Widespread Expansion During 2026 With Alternatives Avaialable

Chronic neurological disorders such as metastatic brain tumors, trigeminal neuralgia, and arteriovenous malformations are complex to treat. Standard brain surgery and radiation therapy can damage healthy tissues and cause various side effects. Moreover, these treatment methods involve in-hospital post treatment care. Gamma knife, which has been introduced decades ago, is one of the most effective non-invasive technologies that is steadily gaining traction in the treatment of tumors. Gamma knife surgery represents a major advancement in brain surgery, with a one-day treatment procedure. Patients can go home the same day after treatment with gamma knife.

Download PDF Brochure of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-pdf/408

Market Dynamics

There are over 2,500 published studies for gamma knife, far more than that for alternative treatment options for brain tumors. Abnormalities measuring less than 1 inch in diameter can be treated with gamma knife. Leksell Gamma Knife is the among most efficient gamma knife devices in the market. The device radiates 201 beams that converge at the lesion point, thus destroying only the affected or target tissue. The device can be programmed to for multiple sessions.

Increasing awareness about the high affectivity of these products and their lowering cost will increase the adoption of this device in the near future. There are a number of centers located globally for gamma knife treatment. Increase in healthcare investments in China, India, Brazil, and other emerging economies would be a major contributing factor towards increase in revenues of the global gamma knife market.

The global gamma knife market was valued at US$ 174.4 million in 2016 and is expected to expand at a CAGR of 7.7% during the forecast period (2017 – 2025).

Non-invasive precision therapy to favor the growth of global gamma knife market

Gamma knife radiotherapy involves convergence of 201 beams that can treat the tumor cell leaving precisely leaving the surrounding healthy cells undamaged. Utilizing the pre-operative diagnostic images form CT/MRI scan, the instrument provides highly accurate irradiation at the tumor site. This is a major factor that drives the usage of gamma knife radiotherapy in treating brain tumors. Application of this procedure is increasing further in trigeminal neuralgia, and arteriovenous malformations. However, gamma knife is limited to 190 positions to reach the tumor cells.

Alternative treatment options include Cyberknife, LINAC radiosurgery, conventional brain surgery, proton therapy, and modified linear accelerators. Gamma knife is the most researched and established radiosurgery. There are over 2,500 published studies for gamma knife.

Request Customization @ https://www.coherentmarketinsights.com/insight/request-customization/408

Gamma knife therapy is considered to be much safer than the open-skull surgeries owing to these factors. The global gamma knife market is expected to grow gradually with increase in awareness. There are more than 300 gamma knife centers worldwide at present, which are estimated to treat nearly 60,000 patients every year. However, there still exists a high demand-supply gap in the countries in pacific region, and Africa continent. China, India, Thailand, South Korea, and Japan are leading countries in terms of the number of gamma knife centers. The gamma knife market is therefore considerable in this region, however behind North America and Europe where the number of gamma knife centers exists far more than Asia.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, 
#3200 
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.